OnDemand
ACC Highlights 2021
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Faculty
  • Agenda
  • Program Materials
  • Funding Support
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

Virtual Exhibit Hall:
Visit the Virtual Exhibit Hall through the link below.

Virtual Sponsor Exhibit
program advertising tile
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

program advertising tile

This program will cover the key clinical trial findings and their implications from ACC 2021.  

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

Milan Gupta
MD, FRCPC, FCCS, CPC(HC)
Brampton, ON
Marc S. Sabatine
MD, MPH
Boston, MA
Narendra Singh
MD, FRCPC, FCCS, FACC, FAHA
Atlanta, GA
Program Chapter
Presenter
COVID-19: Can dapagliflozin, atorvastatin or anticoagulation improve outcomes?
Milan Gupta
Lipids: Icosapent ethyl and heart failure; inclisiran in chronic kidney disease
Narendra Singh
Thrombosis: Left atrial appendage occlusion in atrial fibrillation; anticoagulation following TAVR
Narendra Singh
Heart failure: Neprilysin inhibition for post-MI heart failure; new findings in HFpEF
Milan Gupta

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.

Access CCRN Member Resource Library.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from AstraZeneca, Bayer, BMS-Pfizer Alliance, HLS Therapeutics, Novartis, and Novo Nordisk.

VISIT THE VIRTUAL EXHIBIT HALL

 

 

 

 

 

 

© 2020-2021 MDLearn, All Rights are Reserved